BSE Live
Mar 16, 16:00Prev. Close
2.14
Open Price
2.14
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 05, 15:14Prev. Close
2.10
Open Price
2.10
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
YEAR
EVENTS
2000 - The Union has declared a strike at the company's factory
situated at Village
Savroli, Taluka Khalapur, Khopoli, Dist. Raigad,
Maharashtra.
- The Company's major foray into the business of
biotechnology based products
it was proposed to change the name of the Company from
Kopran Drugs Limited
to KDL Biotech Limited for which necessary approval has
been received from
Registrar of Companies, Maharashtra, Mumbai.
- The Company is a major producer of Semi-synthetic
Penicillins (SSP) and the Enzyme
for converting Penicillin-G to 6APA.
- 71,50,110 Equity Shares of Rs.10/- each were allotted as
fully paid-up as per the Scheme
of Arrangement (01-01-1998) to the Shareholders of
Kopran Limited.
- 57,20,000 12% Optionally Convertible Cummulative
Preference Shares of Rs.100/- each
were alloted as fully paid up as per the Scheme of
Arrangement (01-01-1998) to Kopran Limited.
2001 - Crisil has downgraded the company's NCDs issue to `BB+' from
`BBB'.
2002 - Mr. Nalin Bamzal and Mr. Vijay Bhatia have been appointed as
Additional Directors on the Board.
2003
-The following directors have resigned from the Board of the company:
1. Mr. S J Parekh 2. Mr. Surendra Somani 3. Mr. C L Jain 4. Mr. Vijay
Bhatia 5. Mr. Sen Hong Fang. Further, the following persons have been
appointed as Additional Directors on the Board. 1. Mr. Raman Sharma.
2. Mr. Hardeep Sachdeva. The company has received their consent to
act as Directors.
2004
-KDL Biotech Ltd has informed that Dr. Adil P. Dehnugara's
resignation from the office of Managing Director has been accepted by
the Board at its meeting held on January 30, 2004. He shall vacate the
office of Managing Director on the close of business hours of February
29, 2004. However, he will continue to be a Director of the Company.
2007
- Kdl Biotech Limited has appointed Mr. Dr. Rajesh Agrawal as
additional director on the board with effect from 26th April, 2007.
2009
-Company has created Email Id for registering the Complaints by the
investors n_das@kdlbiotech.in.